Literature DB >> 22462117

Sample size estimation for repeated measures analysis in randomized clinical trials with missing data.

Kaifeng Lu1, Xiaohui Luo, Pei-Yun Chen.   

Abstract

In designing longitudinal studies, researchers must determine the number of subjects to randomize based on the power to detect a clinically meaningful treatment difference and a proposed analysis plan. In this paper, we present formulas for sample size estimation and an assessment of statistical power for a two-treatment repeated measures design allowing for subject attrition. These formulas can be used for comparing two treatment groups across time in terms of linear contrasts. Subjects are assumed to drop out of the study at random so that the missing data do not alter the parameters of interest.

Mesh:

Substances:

Year:  2008        PMID: 22462117     DOI: 10.2202/1557-4679.1098

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  19 in total

1.  A comparison of power analysis methods for evaluating effects of a predictor on slopes in longitudinal designs with missing data.

Authors:  Cuiling Wang; Charles B Hall; Mimi Kim
Journal:  Stat Methods Med Res       Date:  2012-02-21       Impact factor: 3.021

2.  Stress Management in Pre- and Postoperative Care Amongst Practitioners and Patients in Cardiac Catheterization Laboratory: A Study Protocol.

Authors:  Andrea Block; Klaus Bonaventura; Patricia Grahn; Felix Bestgen; Pia-Maria Wippert
Journal:  Front Cardiovasc Med       Date:  2022-07-01

3.  The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.

Authors:  Michael C Donohue; Reisa A Sperling; David P Salmon; Dorene M Rentz; Rema Raman; Ronald G Thomas; Michael Weiner; Paul S Aisen
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

4.  Limitations of clinical trial sample size estimate by subtraction of two measurements.

Authors:  Kewei Chen; Xiaojuan Guo; Rong Pan; Chengjie Xiong; Danielle J Harvey; Yinghua Chen; Li Yao; Yi Su; Eric M Reiman
Journal:  Stat Med       Date:  2021-11-01       Impact factor: 2.373

5.  Selecting a sample size for studies with repeated measures.

Authors:  Yi Guo; Henrietta L Logan; Deborah H Glueck; Keith E Muller
Journal:  BMC Med Res Methodol       Date:  2013-07-31       Impact factor: 4.615

6.  My Activity Coach - using video-coaching to assist a web-based computer-tailored physical activity intervention: a randomised controlled trial protocol.

Authors:  Stephanie Alley; Cally Jennings; Ronald C Plotnikoff; Corneel Vandelanotte
Journal:  BMC Public Health       Date:  2014-07-21       Impact factor: 3.295

7.  Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials.

Authors:  Philip Benjamin; Eva Zeestraten; Christian Lambert; Irina Chis Ster; Owen A Williams; Andrew J Lawrence; Bhavini Patel; Andrew D MacKinnon; Thomas R Barrick; Hugh S Markus
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

8.  Childhood adversity correlates with stable changes in DNA methylation trajectories in children and converges with epigenetic signatures of prenatal stress.

Authors:  Jade Martins; Darina Czamara; Susann Sauer; Monika Rex-Haffner; Katja Dittrich; Peggy Dörr; Karin de Punder; Judith Overfeld; Andrea Knop; Felix Dammering; Sonja Entringer; Sibylle M Winter; Claudia Buss; Christine Heim; Elisabeth B Binder
Journal:  Neurobiol Stress       Date:  2021-05-13

9.  Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies.

Authors:  Denis S Smirnov; Douglas Galasko; Steven D Edland; J Vincent Filoteo; Lawrence A Hansen; David P Salmon
Journal:  Neurology       Date:  2020-04-24       Impact factor: 11.800

10.  Web-Based Video-Coaching to Assist an Automated Computer-Tailored Physical Activity Intervention for Inactive Adults: A Randomized Controlled Trial.

Authors:  Stephanie Alley; Cally Jennings; Ronald C Plotnikoff; Corneel Vandelanotte
Journal:  J Med Internet Res       Date:  2016-08-12       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.